Ward MD - Search Results

1

Proteomic and pathway analyses reveal a network of inflammatory genes associated with differences in skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice.

Shen J, Abel EL, Riggs PK, Repass J, Hensley SC, Schroeder LJ, Temple A, Chau A, McClellan SA, Rho O, Kiguchi K, Ward MD, Semmes OJ, Person MD, Angel JM, Digiovanni J. Shen J, et al. Among authors: ward md. Carcinogenesis. 2012 Nov;33(11):2208-19. doi: 10.1093/carcin/bgs213. Epub 2012 Jul 10. Carcinogenesis. 2012. PMID: 22782996 Free PMC article.

2

Application of mass spectrometry to the discovery of biomarkers for detection of prostate cancer.

Semmes OJ, Malik G, Ward M. Semmes OJ, et al. J Cell Biochem. 2006 Jun 1;98(3):496-503. doi: 10.1002/jcb.20855. J Cell Biochem. 2006. PMID: 16552720 Review.

3

Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients.

Qu Y, Adam BL, Yasui Y, Ward MD, Cazares LH, Schellhammer PF, Feng Z, Semmes OJ, Wright GL Jr. Qu Y, et al. Among authors: ward md. Clin Chem. 2002 Oct;48(10):1835-43. Clin Chem. 2002. PMID: 12324514

4

Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry.

Cazares LH, Adam BL, Ward MD, Nasim S, Schellhammer PF, Semmes OJ, Wright GL Jr. Cazares LH, et al. Among authors: ward md. Clin Cancer Res. 2002 Aug;8(8):2541-52. Clin Cancer Res. 2002. PMID: 12171882

5

Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer.

Malik G, Ward MD, Gupta SK, Trosset MW, Grizzle WE, Adam BL, Diaz JI, Semmes OJ. Malik G, et al. Among authors: ward md. Clin Cancer Res. 2005 Feb 1;11(3):1073-85. Clin Cancer Res. 2005. PMID: 15709174

6

Comparative proteomic analysis of de-N-glycosylated serum from hepatitis B carriers reveals polypeptides that correlate with disease status.

Comunale MA, Mattu TS, Lowman MA, Evans AA, London WT, Semmes OJ, Ward M, Drake R, Romano PR, Steel LF, Block TM, Mehta A. Comunale MA, et al. Proteomics. 2004 Mar;4(3):826-38. doi: 10.1002/pmic.200300625. Proteomics. 2004. PMID: 14997503

7

Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.

Adam BL, Qu Y, Davis JW, Ward MD, Clements MA, Cazares LH, Semmes OJ, Schellhammer PF, Yasui Y, Feng Z, Wright GL Jr. Adam BL, et al. Among authors: ward md. Cancer Res. 2002 Jul 1;62(13):3609-14. Cancer Res. 2002. PMID: 12097261

8

Site-specific phosphorylation differentiates active from inactive forms of the human T-cell leukemia virus type 1 Tax oncoprotein.

Durkin SS, Ward MD, Fryrear KA, Semmes OJ. Durkin SS, et al. Among authors: ward md. J Biol Chem. 2006 Oct 20;281(42):31705-12. doi: 10.1074/jbc.M607011200. Epub 2006 Aug 21. J Biol Chem. 2006. PMID: 16923801 Free article.

9

SELDI protein profiling of dunning R-3327 derived cell lines: identification of molecular markers of prostate cancer progression.

Malik G, Rojahn E, Ward MD, Gretzer MB, Partin AW, Semmes OJ, Veltri RW. Malik G, et al. Among authors: ward md. Prostate. 2007 Oct 1;67(14):1565-75. doi: 10.1002/pros.20646. Prostate. 2007. PMID: 17705230

10

Site-specific phosphorylation regulates human T-cell leukemia virus type 2 Rex function in vivo.

Kesic M, Ward M, Semmes OJ, Green PL. Kesic M, et al. J Virol. 2009 Sep;83(17):8859-68. doi: 10.1128/JVI.00908-09. Epub 2009 Jun 24. J Virol. 2009. PMID: 19553333 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

447 results

Search Page